This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Acacia Pharma Limited. Active years: 2015-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cambridge, GB (2015)
- London, GB (2018)
Company Filing History:
Years Active: 2015-2018
Title: Michael Grant Wyllie: Innovator in Medical Treatments
Introduction
Michael Grant Wyllie is a notable inventor based in London, GB. He has made significant contributions to the field of medicine, particularly in the treatment of xerostomia. With a total of two patents to his name, Wyllie's work has the potential to impact many lives.
Latest Patents
Wyllie's latest patents focus on the use of bethanechol for the treatment of xerostomia. This innovative approach involves administering bethanechol topically, which aims to alleviate the symptoms associated with dry mouth. His research highlights the importance of finding effective treatments for conditions that affect quality of life.
Career Highlights
Wyllie is currently associated with Acacia Pharma Limited, a company dedicated to developing innovative treatments for patients. His work at Acacia Pharma has allowed him to explore new avenues in medical research and contribute to advancements in patient care.
Collaborations
Wyllie has collaborated with notable colleagues, including Nicola Cooper and Julian Clive Gilbert. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Michael Grant Wyllie's contributions to the field of medicine through his patents and collaborations demonstrate his commitment to improving patient outcomes. His work continues to inspire advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile